Garth Lees-Rolfe

Insider Reports History

Entity
Individual
Location
1 Cranberry Hill, Suite 200, Lexington, MA
Signature
/s/ Garth Lees-Rolfe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Garth Lees-Rolfe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 90K Apr 1, 2024 Direct

Insider Reports Filed by Garth Lees-Rolfe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Apr 1, 2024 1 $0 4 Apr 2, 2024 Chief Financial Officer
IKT Inhibikase Therapeutics, Inc. Apr 1, 2024 0 $0 3 Apr 2, 2024 Chief Financial Officer